These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 12420702)
1. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Mischoulon D; Fava M Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702 [TBL] [Abstract][Full Text] [Related]
2. Update and critique of natural remedies as antidepressant treatments. Mischoulon D Obstet Gynecol Clin North Am; 2009 Dec; 36(4):789-807, x. PubMed ID: 19944301 [TBL] [Abstract][Full Text] [Related]
3. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. Papakostas GI J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Delle Chiaie R; Pancheri P; Scapicchio P Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499 [TBL] [Abstract][Full Text] [Related]
5. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine. Fava M; Giannelli A; Rapisarda V; Patralia A; Guaraldi GP Psychiatry Res; 1995 Apr; 56(3):295-7. PubMed ID: 7568552 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Pancheri P; Scapicchio P; Chiaie RD Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028 [TBL] [Abstract][Full Text] [Related]
8. S-adenosyl-methionine in depression: a comprehensive review of the literature. Papakostas GI; Alpert JE; Fava M Curr Psychiatry Rep; 2003 Dec; 5(6):460-6. PubMed ID: 14609501 [TBL] [Abstract][Full Text] [Related]
9. S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Silveri MM; Parow AM; Villafuerte RA; Damico KE; Goren J; Stoll AL; Cohen BM; Renshaw PF Biol Psychiatry; 2003 Oct; 54(8):833-9. PubMed ID: 14550683 [TBL] [Abstract][Full Text] [Related]
10. [Study of the antidepressive effects of a biological transmethylating agent (S-adenosyl-methione or SAM)]. Monaco P; Quattrocchi F Riv Neurol; 1979; 49(6):417-39. PubMed ID: 549212 [TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants. Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327 [TBL] [Abstract][Full Text] [Related]
13. Current Role of Herbal and Natural Preparations. Mischoulon D; Rapaport MH Handb Exp Pharmacol; 2019; 250():225-252. PubMed ID: 30141099 [TBL] [Abstract][Full Text] [Related]
14. S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial. Di Rocco A; Rogers JD; Brown R; Werner P; Bottiglieri T Mov Disord; 2000 Nov; 15(6):1225-9. PubMed ID: 11104210 [TBL] [Abstract][Full Text] [Related]
15. Parenteral S-adenosyl-methionine (SAMe) in depression: literature review and preliminary data. Janicak PG; Lipinski J; Davis JM; Altman E; Sharma RP Psychopharmacol Bull; 1989; 25(2):238-42. PubMed ID: 2690166 [No Abstract] [Full Text] [Related]
16. Efficacy of the dietary supplement S-adenosyl-L-methionine. Fetrow CW; Avila JR Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095 [TBL] [Abstract][Full Text] [Related]